Petros Pharmaceuticals (PTPI) Earnings Report - Discounting Cash Flows
Petros Pharmaceuticals, Inc.
PTPI (NASDAQ)

* (except for per share items) of USD
Period Ending: 2024
11-13
2024
08-14
2024
05-15
2023
11-15
2023
08-21
2023
08-14
2023
04-07
2022
11-15
2022
08-15
2022
05-16
2022
04-01
2021
11-15
2021
08-17
2021
05-17
2021
03-12
2020
12-30
2020
09-30
2020
06-30
2020
03-31
2019
12-31
2019
09-30
2019
06-30
2019
03-31
Actual EPS -0.53 -0.37 -2.05 -2.31 -0.90 -1.20 -7.20 -6.70 -0.90 -0.10 -7.20 -1.70 -4.50 -2.40 3.08 -4.92 -9.61 -16.78 -12.29 -13.03 -66.70 -86.01 -63.42
Estimated EPS -0.29 -0.77 -1.44 - - - - - - - - - - -0.77 - - - - - - - - -
Actual Revenue 1.58 1.42 1.39 -0.36 1.67 1.99 2.52 0.80 -1.46 4.19 2.47 -0.87 2.15 2.46 4.08 2.93 3.46 1.37 1.79 2.10 4.37 4.02 5.09
Estimated Revenue 1.34 1.42 - - - - - - - - - - - 1.40 - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us